Mike Stubbington, PhD |
Tapio Lonnberg, PhD |
DATE: May 26, 2016
TIME: 8am pacific time, 11am eastern time
Join us live and learn about a breakthrough in TCR sequencing using single-cell analysis.
T cells recognize specific antigens via T cell receptors (TCRs), an extremely diverse set of cell surface proteins produced by the rearrangement of germline V(D)J gene segments during T cell development. In the April 2016 issue of Nature Methods, scientists at the European Molecular Biology Laboratory European Bioinformatics Institute (EMBL-EBI) and the Wellcome Trust Sanger Institute (WTSI) published a new approach for single-cell TCR sequencing—an approach that can bring new insights about the response to immunotherapies and cancer vaccines, autoimmune disease, allergy, and vaccine design and efficacy.
Using Fluidigm® single-cell whole transcriptome RNA sequencing on the C1™ system and a novel bioinformatics tool, these researchers reconstructed the full-length, paired TCR sequences from mouse T cells. In this webinar, Michael Stubbington will present TraCeR, a novel bioinformatics tool developed to identify the single-cell TCR sequences, along with graphing functions enabling correlation of clonotype and phenotype for each T cell. Tapio Lönnberg will demonstrate the power of TraCeR analysis to elucidate the cell fate decision process as activated T cell clones differentiate in parallel with both Th1 and Tfh effector cell subsets.
Related Posts
|
Mike Stubbington, PhD |
Tapio Lonnberg, PhD |
DATE: May 26, 2016
TIME: 8am pacific time, 11am eastern time
Join us live and learn about a breakthrough in TCR sequencing using single-cell analysis.
T cells recognize specific antigens via T cell receptors (TCRs), an extremely diverse set of cell surface proteins produced by the rearrangement of germline V(D)J gene segments during T cell development. In the April 2016 issue of Nature Methods, scientists at the European Molecular Biology Laboratory European Bioinformatics Institute (EMBL-EBI) and the Wellcome Trust Sanger Institute (WTSI) published a new approach for single-cell TCR sequencing—an approach that can bring new insights about the response to immunotherapies and cancer vaccines, autoimmune disease, allergy, and vaccine design and efficacy.
Using Fluidigm® single-cell whole transcriptome RNA sequencing on the C1™ system and a novel bioinformatics tool, these researchers reconstructed the full-length, paired TCR sequences from mouse T cells. In this webinar, Michael Stubbington will present TraCeR, a novel bioinformatics tool developed to identify the single-cell TCR sequences, along with graphing functions enabling correlation of clonotype and phenotype for each T cell. Tapio Lönnberg will demonstrate the power of TraCeR analysis to elucidate the cell fate decision process as activated T cell clones differentiate in parallel with both Th1 and Tfh effector cell subsets.
Related Posts
Recent Posts
New method allows scientists to follow gene activity over time in the same cells
Single-cell and single-embryo RNA sequencing
RNA sequencing reveals functional chimeric mRNAs in mammalian immunity
Deep learning improves microRNA target prediction from sequence
New Johns Hopkins Study Identifies Pervasive RT-qPCR Artifact in CRISPR Knockdown Studies and How UltraMarathonRT® Solves It
Atlas of the brain’s striatum could guide researchers to new drug treatments
RNA-Seq Products & Services
Stay Connected